Presentation information
Evening Seminar
[ES-05] Novartis Pharma K.K
The position of L-dopa therapy in the new Parkinson's Disease clinical guideline
Fri. May 25, 2018 5:30 PM - 6:30 PM Room 8 (Royton Sapporo / Empress Hall (2F))
Chair: Miho Murata(National Center of Neurology and Psychiatry Director General)